Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Avipattikar Churna is a traditional Ayurvedic polyherbal formulation used primarily for the treatment of digestive ailments related to Pitta dosha imbalance, such as hyperacidity, gastritis, and constipation. The formulation consists of 14 ingredients, including Trikatu (ginger and peppers), Triphala (three myrobalans), and a significant proportion of Operculina turpethum (Trivrit) and Syzygium aromaticum (clove). Its therapeutic efficacy is attributed to its antacid, anti-secretory, and mild laxative properties. Mechanistically, it works by neutralizing excess gastric acid and potentially inhibiting the H+/K+ ATPase pump, while its high fiber and glycoside content from Trivrit promotes bowel regularity. It is a staple in Ayurvedic practice and is manufactured by numerous traditional medicine companies in India, where it is officially recognized in the Ayurvedic Pharmacopoeia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Avipattikar Churna.